Mitochondrial superoxide production and nuclear factor erythroid 2-related factor 2 activation in p75 neurotrophin receptor-induced motor neuron apoptosis.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Society for Neuroscience Country of Publication: United States NLM ID: 8102140 Publication Model: Print Cited Medium: Internet ISSN: 1529-2401 (Electronic) Linking ISSN: 02706474 NLM ISO Abbreviation: J Neurosci Subsets: MEDLINE
    • Publication Information:
      Publication: Washington, DC : Society for Neuroscience
      Original Publication: [Baltimore, Md.] : The Society, c1981-
    • Subject Terms:
    • Abstract:
      Nerve growth factor (NGF) can induce apoptosis by signaling through the p75 neurotrophin receptor (p75(NTR)) in several nerve cell populations. Cultured embryonic motor neurons expressing p75(NTR) are not vulnerable to NGF unless they are exposed to an exogenous flux of nitric oxide (*NO). In the present study, we show that p75(NTR)-mediated apoptosis in motor neurons involved neutral sphingomyelinase activation, increased mitochondrial superoxide production, and cytochrome c release to the cytosol. The mitochondria-targeted antioxidants mitoQ and mitoCP prevented neuronal loss, further evidencing the role of mitochondria in NGF-induced apoptosis. In motor neurons overexpressing the amyotrophic lateral sclerosis (ALS)-linked superoxide dismutase 1(G93A) (SOD1(G93A)) mutation, NGF induced apoptosis even in the absence of an external source of *NO. The increased susceptibility of SOD1(G93A) motor neurons to NGF was associated to decreased nuclear factor erythroid 2-related factor 2 (Nrf2) expression and downregulation of the enzymes involved in glutathione biosynthesis. In agreement, depletion of glutathione in nontransgenic motor neurons reproduced the effect of SOD1(G93A) expression, increasing their sensitivity to NGF. In contrast, rising antioxidant defenses by Nrf2 activation prevented NGF-induced apoptosis. Together, our data indicate that p75(NTR)-mediated motor neuron apoptosis involves ceramide-dependent increased mitochondrial superoxide production. This apoptotic pathway is facilitated by the expression of ALS-linked SOD1 mutations and critically modulated by Nrf2 activity.
    • References:
      Eur J Neurosci. 1999 May;11(5):1668-76. (PMID: 10215920)
      Mol Pharmacol. 1999 Nov;56(5):867-74. (PMID: 10531389)
      Prog Neurobiol. 2000 Jun;61(2):205-29. (PMID: 10704998)
      Cell Tissue Res. 2000 Jul;301(1):71-84. (PMID: 10928282)
      Eur J Biochem. 2000 Aug;267(16):4912-6. (PMID: 10931173)
      J Biol Chem. 2001 Feb 16;276(7):4588-96. (PMID: 11092892)
      J Neurosci Res. 2001 Apr 1;64(1):11-7. (PMID: 11276046)
      J Biol Chem. 2001 Sep 7;276(36):33812-20. (PMID: 11451944)
      Amyotroph Lateral Scler Other Motor Neuron Disord. 2001 Sep;2(3):127-34. (PMID: 11771768)
      J Biol Chem. 2002 Mar 22;277(12):9812-8. (PMID: 11777929)
      Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1604-9. (PMID: 11818550)
      Chembiochem. 2001 Feb 2;2(2):141-3. (PMID: 11828438)
      Trends Neurosci. 2001 Nov;24(11 Suppl):S15-20. (PMID: 11881740)
      J Neurochem. 2002 Jun;81(6):1233-41. (PMID: 12068071)
      Adv Enzyme Regul. 2002;42:113-29. (PMID: 12123710)
      J Biol Chem. 2002 Oct 25;277(43):41128-39. (PMID: 12154098)
      Ann Neurol. 2002 Oct;52(4):448-57. (PMID: 12325074)
      Neuron. 2002 Sep 12;35(6):1067-83. (PMID: 12354397)
      Annu Rev Pharmacol Toxicol. 2003;43:233-60. (PMID: 12359864)
      Free Radic Biol Med. 2002 Dec 1;33(11):1451-64. (PMID: 12446202)
      J Biol Chem. 2003 Apr 4;278(14):12029-38. (PMID: 12556532)
      Neuroscience. 2003;116(3):685-94. (PMID: 12573711)
      Nat Rev Neurosci. 2003 Apr;4(4):299-309. (PMID: 12671646)
      Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5407-12. (PMID: 12697897)
      FASEB J. 2003 Oct;17(13):1972-4. (PMID: 12923074)
      Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Jun;4(2):100-5. (PMID: 14506941)
      J Neurochem. 2003 Nov;87(3):752-63. (PMID: 14535957)
      J Neurosci Res. 2003 Nov 15;74(4):605-13. (PMID: 14598305)
      J Neurosci. 2003 Dec 10;23(36):11373-81. (PMID: 14673001)
      Prog Brain Res. 2004;146:25-39. (PMID: 14699954)
      Biochem Cell Biol. 2004 Feb;82(1):27-44. (PMID: 15052326)
      J Neurochem. 2004 Apr;89(2):464-73. (PMID: 15056289)
      J Neurosci. 2004 May 12;24(19):4498-509. (PMID: 15140920)
      Neuron. 2004 May 27;42(4):529-33. (PMID: 15157416)
      J Biol Chem. 2004 Sep 3;279(36):37575-87. (PMID: 15220329)
      Curr Opin Neurobiol. 2005 Feb;15(1):49-57. (PMID: 15721744)
      Brain. 2005 Jul;128(Pt 7):1686-706. (PMID: 15872021)
      FASEB J. 2005 Jul;19(9):1088-95. (PMID: 15985532)
      Free Radic Biol Med. 2005 Sep 1;39(5):567-83. (PMID: 16085176)
      J Neurochem. 2006 May;97(3):687-96. (PMID: 16524372)
      Brain Res. 1991 May 24;549(2):297-304. (PMID: 1653083)
      Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15038-43. (PMID: 17015830)
      Free Radic Biol Med. 2006 Dec 1;41(11):1632-44. (PMID: 17145551)
      Science. 1994 Sep 9;265(5178):1596-9. (PMID: 8079174)
      Cell. 1994 Jun 3;77(5):627-38. (PMID: 8205613)
      Brain Res. 1993 Sep 3;621(1):111-5. (PMID: 8221061)
      J Neurobiol. 1993 Dec;24(12):1555-77. (PMID: 8301265)
      Nature. 1993 May 20;363(6426):266-70. (PMID: 8487864)
      J Comp Neurol. 1995 Dec 11;363(2):249-63. (PMID: 8642073)
      Nature. 1996 Oct 24;383(6602):716-9. (PMID: 8878481)
      Am J Physiol. 1996 Nov;271(5 Pt 1):C1424-37. (PMID: 8944624)
      J Biol Chem. 1997 Apr 25;272(17):11369-77. (PMID: 9111045)
      J Biol Chem. 1997 Aug 22;272(34):21388-95. (PMID: 9261153)
      J Biol Chem. 1997 Sep 26;272(39):24154-8. (PMID: 9305864)
      J Neurosci. 1998 Feb 1;18(3):923-31. (PMID: 9437014)
      J Neurobiol. 1998 Jan;34(1):1-9. (PMID: 9469614)
      J Neurosci. 1998 May 1;18(9):3273-81. (PMID: 9547236)
      Ann N Y Acad Sci. 1998 Jun 19;845:32-45. (PMID: 9668341)
      J Neurosci Res. 1998 Nov 15;54(4):465-74. (PMID: 9822157)
    • Grant Information:
      P30 ES000210 United States ES NIEHS NIH HHS; R03TW006482 United States TW FIC NIH HHS; P01 ES000040 United States ES NIEHS NIH HHS; AT02034 United States AT NCCIH NIH HHS; R03 TW006482 United States TW FIC NIH HHS; P01 AT002034 United States AT NCCIH NIH HHS; ES00040 United States ES NIEHS NIH HHS; ES00210 United States ES NIEHS NIH HHS
    • Accession Number:
      0 (Enzyme Inhibitors)
      0 (NF-E2-Related Factor 2)
      0 (Nfe2l2 protein, rat)
      0 (Nitric Oxide Donors)
      0 (Nitroso Compounds)
      0 (Oligodeoxyribonucleotides, Antisense)
      0 (Reactive Oxygen Species)
      0 (Receptor, Nerve Growth Factor)
      146724-94-9 (2,2'-(hydroxynitrosohydrazono)bis-ethanamine)
      9007-43-6 (Cytochromes c)
      9061-61-4 (Nerve Growth Factor)
      EC 1.15.1.1 (SOD1 G93A protein)
      EC 1.15.1.1 (Superoxide Dismutase)
      EC 3.1.4.12 (Sphingomyelin Phosphodiesterase)
    • Publication Date:
      Date Created: 20070720 Date Completed: 20070823 Latest Revision: 20230131
    • Publication Date:
      20240829
    • Accession Number:
      PMC6672870
    • Accession Number:
      10.1523/JNEUROSCI.0823-07.2007
    • Accession Number:
      17634371